Servatus Biopharmaceuticals
Samantha joined Servatus in 2018 to Head the Clinical Research Department, bringing extensive knowledge of the human microbiome and use of bacteria as therapeutic drugs. With a PhD in Medicine from the University of Queensland, Samantha has a diverse background in the Biotechnology Industry with in-depth knowledge and experience in designing, initiating, conducting, and collaborating on multidisciplinary human clinical trial projects involving autoimmune, inflammatory and infectious diseases. Samantha’s current role within Servatus is to manage the clinical trial pipeline, ensuring Servatus’ human clinical trial projects meet the designated timelines from conception to initiation and completion. Working closely with the Principal Investigators, Samantha ensures meticulous detail in the design of Servatus’ clinical trials; supported by a skilled, dedicated and talented clinical research team.
Servatus Biopharmaceuticals
Servatus is focused on the development of effective treatments for chronic and inflammatory diseases - especially auto-immune diseases.